Rhomboid Intercostal and Subserratus Plane (RISS) Block on Postoperative Painafter Open Nephrectomy Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

EARLY_PHASE1

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-21

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rhomboid intercostal block (RIB) is a new interfascial plane block describe by Elsharkawy et al. in 2016. The region described is understood because the triangle of auscultation that's bounded medially by inferior a part of the trapezius, inferiorly by the superior border of latissimus dorsi, and laterally by the medial border of the scapula. In this ultrasound-guided block, the local anaesthetic drug is run between the rhomboid major and therefore the intercostal fascia at the extent of T6-T7 and provides analgesia of T3-T8 dermatomes

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Rhomboid Intercostal and Subserratus Plane Block Versus Quadratus Lumborum Block in Management of Postoperative Pain After Open Nephrectomy

NCT06983249

Open Nephrectomy Surgery

ACTIVE_NOT_RECRUITING NA

Ultrasound Guided Rhomboid Intercostal Subserratus Plane Block vs Erector Spinae Plane Block in Open Nephrectomy

NCT05822011

Post Operative Pain

COMPLETED NA

Rhomboid Intercostal and Sub-serratus Block

NCT04859803

Rhomboid Intercostal Block

COMPLETED EARLY_PHASE1

Ultrasound Guided Rhomboid Intercostal Block for Myofascial Pain Syndrome

NCT04751110

Myofascial Pain Syndrome

COMPLETED NA

Rhomboid Intercostal Sub Serratus Plane Block Versus Serratus Anterior Plane Block in Thoractomy

NCT06856538

Thoracic Pain

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rhomboid Intercostal Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

patients will receive sham block.

Group Type SHAM_COMPARATOR

Rhomboid Intercostal and Sub-Serratus block

Intervention Type DRUG

Rhomboid Intercostal and Sub-Serratus block under ultrasound guidance

RISS group

will receive Rhomboid Intercostal and Sub-Serratus block under ultrasound guidance

Group Type ACTIVE_COMPARATOR

Rhomboid Intercostal and Sub-Serratus block

Intervention Type DRUG

Rhomboid Intercostal and Sub-Serratus block under ultrasound guidance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rhomboid Intercostal and Sub-Serratus block

Rhomboid Intercostal and Sub-Serratus block under ultrasound guidance

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Inclusion criteria Adult patients between 18-60 years.

Exclusion Criteria

Genders eligible for study: both sexes ASA physical status I and II Undergoing open nephrectomy surgery * Exclusion criteria Patient refusal Contraindications to regional anesthesia Known allergy to local anesthetics Bleeding disorders Use of any anti-coagulants Inability to provide informed consent ASA III-IV

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes